Author:
van Basten Jean-Paul A.,Hoekstra Harald J.,van Driel Mels F.,Sleijfer Dirk Th.,Droste Jos H. J.,Koops Heimen Schraffordt
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Stoter G, Koopman A, Vendrik CPJ, Struyvenberg A, Sleijfer DTh, Willemse PHB, Schraffordt Koops H, et al. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine and bleomycin.J Clin Oncol 1989;7:1099–104.
2. Bokemeyer C, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies.J Clin Oncol 1995;13:283–92.
3. Willemse PHB, Sleijfer DTh, Schraffordt Koops H, Pratt JJ, Sluiter W, Doorenbos H. Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect.Acta Endocrinol 1983;6:497–508.
4. Oliver RTD, Ong J, Ying XL, Boshoff C, Newlands ES, Begent RHJ, Rustin GJ. Justification for testis conserving chemotherapy trials in germ cell cancer.Proc Am Soc Clin Oncol 1995;14:614.
5. Van Leeuwen FE, Stiggelbout AM, Van den Belt-Dusebout AW, Noyon R, Eliel MR, Van Kerkhoff EHM, Delemarre JFM, et al. Second cancer risk following testicular cancer: a follow-up of 1,909 patients.J Clin Oncol 1993;11:415–24.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献